Credit Suisse Ag Omnicell, Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Omnicell, Inc stock. As of the latest transaction made, Credit Suisse Ag holds 107,703 shares of OMCL stock, worth $4.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

107,703

Previous 680,058 84.16%

Holding current value

$4.14 Million

Previous $25.6 Million 87.7%

% of portfolio

0.0%

Previous 0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$26.15 - $37.33 $15 Million - $21.4 Million	-572,355 Reduced 84.16%	107,703 $3.15 Million
Q4 2023 Feb 08, 2024	SELL	$29.24 - $45.81 $11.1 Million - $17.3 Million	-378,233 Reduced 35.74%	680,058 $25.6 Million
Q3 2023 Nov 13, 2023	SELL	$44.6 - $73.38 $102,044 - $167,893	-2,288 Reduced 0.22%	1,058,291 $47.7 Million
Q2 2023 Aug 11, 2023	SELL	$57.88 - $75.94 $11.1 Million - $14.6 Million	-192,110 Reduced 15.34%	1,060,579 $78.1 Million
Q1 2023 May 10, 2023	SELL	$51.51 - $60.43 $1.63 Million - $1.91 Million	-31,663 Reduced 2.47%	1,252,689 $73.5 Million
Q4 2022 Feb 13, 2023	BUY	$46.24 - $90.03 $101,173 - $196,985	2,188 Added 0.17%	1,284,352 $64.8 Million
Q3 2022 Nov 10, 2022	BUY	$84.23 - $117.38 $6.11 Million - $8.51 Million	72,542 Added 6.0%	1,282,164 $112 Million
Q2 2022 Aug 12, 2022	BUY	$105.64 - $129.11 $11.3 Million - $13.8 Million	106,749 Added 9.68%	1,209,622 $138 Million
Q1 2022 May 16, 2022	BUY	$120.68 - $180.51 $44.3 Million - $66.2 Million	366,835 Added 49.84%	1,102,873 $143 Million
Q4 2021 Feb 14, 2022	SELL	$153.26 - $183.62 $330,888 - $396,435	-2,159 Reduced 0.29%	736,038 $133 Million
Q3 2021 Nov 12, 2021	SELL	$141.84 - $160.88 $24.9 Million - $28.2 Million	-175,225 Reduced 19.18%	738,197 $110 Million
Q2 2021 Aug 16, 2021	SELL	$129.91 - $151.45 $27.9 Million - $32.5 Million	-214,791 Reduced 19.04%	913,422 $138 Million
Q1 2021 May 14, 2021	SELL	$117.78 - $143.9 $26.7 Million - $32.7 Million	-226,904 Reduced 16.74%	1,128,213 $147 Million
Q4 2020 Feb 12, 2021	SELL	$73.85 - $120.02 $25.9 Million - $42 Million	-350,178 Reduced 20.53%	1,355,117 $163 Million
Q3 2020 Nov 13, 2020	BUY	$63.15 - $77.12 $2.96 Million - $3.62 Million	46,938 Added 2.83%	1,705,295 $127 Million
Q2 2020 Aug 12, 2020	BUY	$59.36 - $74.43 $12.7 Million - $16 Million	214,675 Added 14.87%	1,658,357 $117 Million
Q1 2020 May 13, 2020	SELL	$55.41 - $90.19 $1.47 Million - $2.39 Million	-26,498 Reduced 1.8%	1,443,682 $94.7 Million
Q4 2019 Feb 12, 2020	BUY	$70.15 - $83.11 $6.99 Million - $8.28 Million	99,580 Added 7.27%	1,470,180 $120 Million
Q3 2019 Nov 12, 2019	BUY	$68.36 - $88.34 $42.7 Million - $55.2 Million	625,120 Added 83.85%	1,370,600 $99.1 Million
Q2 2019 Aug 14, 2019	BUY	$71.38 - $92.21 $19.1 Million - $24.6 Million	267,324 Added 55.91%	745,480 $64.1 Million
Q1 2019 May 14, 2019	BUY	$58.88 - $86.19 $5.85 Million - $8.56 Million	99,318 Added 26.22%	478,156 $38.7 Million
Q4 2018 Feb 13, 2019	BUY	$56.97 - $77.23 $3.95 Million - $5.36 Million	69,342 Added 22.4%	378,838 $23.2 Million
Q3 2018 Nov 13, 2018	BUY	$52.65 - $71.9 $14.7 Million - $20 Million	278,331 Added 893.09%	309,496 $22.3 Million
Q2 2018 Aug 14, 2018	SELL	$42.2 - $53.05 $199,943 - $251,350	-4,738 Reduced 13.2%	31,165 $1.64 Million
Q1 2018 May 15, 2018	BUY	$40.1 - $52.45 $48,962 - $64,041	1,221 Added 3.52%	35,903 $1.56 Million
Q4 2017 Feb 14, 2018	SELL	$45.3 - $54.5 $329,557 - $396,487	-7,275 Reduced 17.34%	34,682 $1.68 Million
Q3 2017 Nov 14, 2017	BUY	$48.1 - $52.15 $1.15 Million - $1.25 Million	23,908 Added 132.46%	41,957 $2.14 Million
Q2 2017 Aug 14, 2017	BUY	N/A	18,049	18,049 $778,000

Others Institutions Holding OMCL

# of Institutions

299

Shares Held

45.8M

Call Options Held

858K

Put Options Held

75.6K

View Full List

About OMNICELL, Inc

Ticker OMCL
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 44,288,800
Market Cap $1.7B
Description
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...

More about OMCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account